Morgan Stanley’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $678K | Sell |
201,094
-266,132
| -57% | -$897K | ﹤0.01% | 5314 |
|
|
2025
Q1 | $710K | Buy |
467,226
+13,126
| +3% | +$20K | ﹤0.01% | 5169 |
|
|
2024
Q4 | $999K | Buy |
454,100
+4,789
| +1% | +$10.5K | ﹤0.01% | 5090 |
|
|
2024
Q3 | $1.12M | Buy |
449,311
+403,259
| +876% | +$1M | ﹤0.01% | 4990 |
|
|
2024
Q2 | $58.9K | Buy |
46,052
+433
| +0.9% | +$554 | ﹤0.01% | 6123 |
|
|
2024
Q1 | $132K | Sell |
45,619
-66,677
| -59% | -$193K | ﹤0.01% | 5883 |
|
|
2023
Q4 | $825K | Buy |
112,296
+91,013
| +428% | +$669K | ﹤0.01% | 5391 |
|
|
2023
Q3 | $163K | Sell |
21,283
-4,392
| -17% | -$33.7K | ﹤0.01% | 5672 |
|
|
2023
Q2 | $260K | Sell |
25,675
-1,976
| -7% | -$20K | ﹤0.01% | 5522 |
|
|
2023
Q1 | $268K | Sell |
27,651
-17,765
| -39% | -$172K | ﹤0.01% | 5572 |
|
|
2022
Q4 | $220K | Buy |
45,416
+33,667
| +287% | +$163K | ﹤0.01% | 5626 |
|
|
2022
Q3 | $168K | Sell |
11,749
-6,538
| -36% | -$93.5K | ﹤0.01% | 5809 |
|
|
2022
Q2 | $98K | Sell |
18,287
-137
| -0.7% | -$734 | ﹤0.01% | 6285 |
|
|
2022
Q1 | $119K | Buy |
18,424
+7,787
| +73% | +$50.3K | ﹤0.01% | 6215 |
|
|
2021
Q4 | $172K | Buy |
10,637
+3,929
| +59% | +$63.5K | ﹤0.01% | 6142 |
|
|
2021
Q3 | $178K | Buy |
+6,708
| New | +$178K | ﹤0.01% | 6060 |
|